Completed |
: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
: - Brenner Tumor
- Fallopian Tube Cancer
: 2004-06-10
: - Drug: carboplatin Given intrap
|
Active, not recruiting |
: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
: - Cognitive Side Effects of Cancer Therapy
- Malignant Ovarian Epithelial Tumor
-
- Procedure: Cognitive Assessment
|
Completed |
: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
: - Fallopian Tube Carcinoma
- Infectious Disorder
- Neutropenia
: 2006-07-13
: - Procedure: Adjuvant Therapy
- Drug: Carbopla
|
Recruiting |
: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
: - Cervical Adenosarcoma
- Cervical Adenosquamous Carcinoma
- Cer
: 2013-12-19
: - Biological: Bevacizumab Given
|
Active, not recruiting |
: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
: - Adult Hepatocellular Carcinoma
- Advanced Adult Hepatocellular Carcinoma
-
- Biological: Bevacizumab Given
|
Active, not recruiting |
: Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
: - Fallopian Tube Carcinosarcoma
- Fallopian Tube Clear Cell Adenocarcinoma
-
- Biological: Bevacizumab Given
|
Active, not recruiting |
: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2009-02-05
: - Drug: carboplatin Given IV in
|
Completed |
: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
: - Cervical Cancer
- Fallopian Tube Cancer
- Head and Neck Cancer
: 2003-08-06
: Biological: SS1(dsFv)-PE38 immunotoxin
|
Completed |
: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2007-06-06
: - Biological: bevacizumab
- Drug: carboplatin
|
Terminated |
: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
: Cancer
: 2010-05-26
: - Drug: cyproheptadine hydrochloride
|